{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:52:51Z","timestamp":1790553171698,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Optometry - Journal of the American Optometric Association"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.optm.2010.01.015","type":"journal-article","created":{"date-parts":[[2011,1,26]],"date-time":"2011-01-26T09:21:34Z","timestamp":1296033694000},"page":"92-103","source":"Crossref","is-referenced-by-count":50,"title":["Rosacea and its ocular manifestations"],"prefix":"10.1016","volume":"82","author":[{"given":"Melissa","family":"Oltz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Check","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.optm.2010.01.015_bib1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.optm.2010.01.015_bib2","first-page":"1","article-title":"Rosacea and its topical management","volume":"14","author":"Gooderham","year":"2009","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.optm.2010.01.015_bib3","first-page":"461","article-title":"Treatment of acne rosacea reviewed","volume":"80","author":"Barclay","year":"2009","journal-title":"Am Fam Physician"},{"issue":"5","key":"10.1016\/j.optm.2010.01.015_bib4","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/01.ico.0000158989.81853.64","article-title":"Dendritic keratopathy in ocular rosacea","volume":"24","author":"Lee","year":"2005","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.optm.2010.01.015_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/ICO.0b013e31802e3a54","article-title":"Evaluation and treatment of children with ocular rosacea","volume":"26","author":"Donaldson","year":"2007","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.optm.2010.01.015_bib6","first-page":"33","article-title":"Identifying and treating ocular rosacea","volume":"27","author":"Dennis","year":"2003","journal-title":"Physician Assistant"},{"issue":"3","key":"10.1016\/j.optm.2010.01.015_bib7","first-page":"299","article-title":"Treatment of papulopustular rosacea with sodium sulfacetamide 10%\/sulfur 5% emollient foam","volume":"8","author":"Trumbore","year":"2009","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.optm.2010.01.015_bib8","first-page":"38","article-title":"Rosacea: A review","volume":"34","author":"Culp","year":"2009","journal-title":"Pharm Ther"},{"issue":"1","key":"10.1016\/j.optm.2010.01.015_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00003226-200401000-00020","article-title":"Oral tetracyclines for ocular rocasea: An evidence-based review of the literature","volume":"23","author":"Stone","year":"2004","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.optm.2010.01.015_bib10","first-page":"97","article-title":"Standard management options for rosacea, Part 2: Options according to subtype","volume":"84","author":"Odom","year":"2009","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.optm.2010.01.015_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archderm.1997.03890370055009","article-title":"Ocular rosacea: Signs, symptoms, and tear studies before and after treatment with doxycycline","volume":"133","author":"Quarterman","year":"1997","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.optm.2010.01.015_bib12","first-page":"461","article-title":"Treatment options for acne rosacea","volume":"80","author":"Goldgar","year":"2009","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.optm.2010.01.015_bib13","first-page":"84","article-title":"Basic and Clinical Science Course, Section 8. External Disease and Cornea","author":"Sutphin","year":"2006","journal-title":"American Academy of Ophthalmology"},{"issue":"1","key":"10.1016\/j.optm.2010.01.015_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archderm.1997.03890370095014","article-title":"Ocular rosacea: Current concepts and therapy","volume":"133","author":"Kligman","year":"1997","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.optm.2010.01.015_bib15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMcp042829","article-title":"Clinical practice: Rosacea","volume":"352","author":"Powell","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.optm.2010.01.015_bib16","unstructured":"Randleman JB, Loft E, Song CD. Ocular rosacea. eMedicine from WebMD. Available at: http:\/\/www.emedicine.com\/OPH\/topic115.htm. 2009. Last accessed October 26, 2009."},{"issue":"1","key":"10.1016\/j.optm.2010.01.015_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1517\/14656566.5.1.5","article-title":"Medical treatment of rosacea with emphasis on topical therapies","volume":"5","author":"Del Rosso","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.optm.2010.01.015_bib18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4103\/0378-6323.53146","article-title":"Correlation of the severity of cutaneous rosacea with ocular rosacea","volume":"75","author":"Keshtcar-Jafari","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.optm.2010.01.015_bib19","first-page":"1863","article-title":"Ocular rosacea. Patient characteristics and follow-up","volume":"104","author":"Apek","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.optm.2010.01.015_bib20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00003226-200304000-00009","article-title":"The prevalence of ocular signs in acne rosacea","volume":"22","author":"Ghanem","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.optm.2010.01.015_bib21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0002-9394(43)91857-4","article-title":"Ocular rosacea","volume":"26","author":"Wise","year":"1943","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.optm.2010.01.015_bib22","first-page":"183","article-title":"Facial hygiene and comprehensive management of rosacea","volume":"73","author":"Draelos","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.optm.2010.01.015_bib23","series-title":"The Wills Eye Manual: Office and emergency room diagnosis and treatment of eye disease. 4th ed","author":"Friedberg","year":"2004"},{"key":"10.1016\/j.optm.2010.01.015_bib24","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/00003226-200108000-00024","article-title":"Pseudokeratoconus caused by rosacea","volume":"20","author":"Dursun","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.optm.2010.01.015_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archdermatol.2007.50","article-title":"Cutaneous and ocular signs of childhood rosacea","volume":"144","author":"Chamaillard","year":"2008","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.optm.2010.01.015_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdermsci.2009.04.007","article-title":"The molecular pathology of rosacea","volume":"55","author":"Yamasaki","year":"2009","journal-title":"J Dermatol Sci"},{"issue":"1","key":"10.1016\/j.optm.2010.01.015_bib27","first-page":"80","article-title":"Persistent eyelid swelling in a patient with rosacea","volume":"28","author":"Morales-Burgos","year":"2009","journal-title":"P R Health Sci J"},{"issue":"8","key":"10.1016\/j.optm.2010.01.015_bib28","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1468-3083.2009.03167.x","article-title":"Current topical and systemic approaches to treatment of rosacea","volume":"23","author":"Korting","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.optm.2010.01.015_bib29","first-page":"43","article-title":"Standard management options for rosacea, Part 1: Overview and broad spectrum of care","volume":"84","author":"Odom","year":"2009","journal-title":"Cutis"},{"issue":"3","key":"10.1016\/j.optm.2010.01.015_bib30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jaad.2008.10.058","article-title":"Demodicosis: A clinicopathological study","volume":"60","author":"Hsu","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.optm.2010.01.015_bib31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0190-9622(99)70493-7","article-title":"Helicobacter pylori eradication treatment reduces the severity of rosacea","volume":"40","author":"Utas","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.optm.2010.01.015_bib32","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archderm.135.6.659","article-title":"Effect of treatment of Helicobacter pylori infection on rosacea","volume":"135","author":"Bamford","year":"1999","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.optm.2010.01.015_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2310\/7750.2008.07088","article-title":"Granulomatous periorificial dermatitis: A variant of granulomatous rosacea in children?","volume":"13","author":"Lucas","year":"2009","journal-title":"J Cutan Med Surg"},{"issue":"4","key":"10.1016\/j.optm.2010.01.015_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/MOO.0b013e32832d75e3","article-title":"Management of benign skin lesions commonly affecting the face: Actinic keratosis, seborrheic keratosis, and rosacea","volume":"17","author":"Brodsky","year":"2009","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"5","key":"10.1016\/j.optm.2010.01.015_bib35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-4632.2004.02283.x","article-title":"Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide\/clindamycin topical gel in the treatment of patients with moderate to severe rosacea","volume":"43","author":"Breneman","year":"2004","journal-title":"Int J Dermatol"},{"issue":"6 Pt 1","key":"10.1016\/j.optm.2010.01.015_bib36","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0190-9622(99)70085-X","article-title":"A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with\u00a0papulopustular rosacea","volume":"40","author":"Maddin","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.optm.2010.01.015_bib37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/14764170902741311","article-title":"Quality of life and rosacea: Pulsed dye laser impact","volume":"11","author":"Menezes","year":"2009","journal-title":"J Cosmet Laser Ther"},{"issue":"6","key":"10.1016\/j.optm.2010.01.015_bib38","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1524-4725.2009.01156.x","article-title":"Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea","volume":"35","author":"Neuhaus","year":"2009","journal-title":"Dermatol Surg"},{"issue":"2 Suppl","key":"10.1016\/j.optm.2010.01.015_bib39","first-page":"6","article-title":"Photodynamic therapy for the treatment of erythema, papules, pustules, and severe flushing consistent with rosacea","volume":"5","author":"Katz","year":"2006","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"10.1016\/j.optm.2010.01.015_bib40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.survophthal.2009.02.002","article-title":"Topical ophthalmic cyclosporine: Pharmacology and clinical uses","volume":"54","author":"Donnenfeld","year":"2009","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.optm.2010.01.015_bib41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3129\/i09-015","article-title":"Management of dysfunctional tear syndrome: A Canadian consensus","volume":"44","author":"Jackson","year":"2009","journal-title":"Can J Ophthalmol"},{"issue":"6","key":"10.1016\/j.optm.2010.01.015_bib42","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12325-009-0037-2","article-title":"Efficacy of topical cyclosporine for the treatment of ocular rosacea","volume":"26","author":"Schechter","year":"2009","journal-title":"Adv Ther"},{"issue":"4","key":"10.1016\/j.optm.2010.01.015_bib43","first-page":"2","article-title":"New considerations in the treatment of anterior and posterior blepharitis. A continuing medical education supplement to refractive eyecare","volume":"12","author":"Donnenfeld","year":"2008","journal-title":"Ethis Communications, Inc"},{"issue":"7","key":"10.1016\/j.optm.2010.01.015_bib44","first-page":"639","article-title":"A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy","volume":"8","author":"Thiboutot","year":"2009","journal-title":"J Drugs Dermatol"},{"issue":"15","key":"10.1016\/j.optm.2010.01.015_bib45","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1517\/14656566.9.15.2699","article-title":"Azelaic acid 15% gel in the treatment of rosacea","volume":"9","author":"Gollnick","year":"2008","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"10.1016\/j.optm.2010.01.015_bib46","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-4632.2005.02769.x","article-title":"Azelaic acid (15% gel) in the treatment of acne rosacea","volume":"46","author":"Gupta","year":"2007","journal-title":"Int J Dermatol"},{"issue":"8","key":"10.1016\/j.optm.2010.01.015_bib47","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/archderm.142.8.1047","article-title":"Azelaic acid in the treatment of papulopustular rosacea: A systematic review of randomized controlled trials","volume":"142","author":"Liu","year":"2006","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.optm.2010.01.015_bib48","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jaad.2004.01.048","article-title":"Standard grading system for rosacea: Report of the National Rosacea Society Expert Committee on the classification and staging of rosacea","volume":"50","author":"Wilkin","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.optm.2010.01.015_bib49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaad.2006.04.084","article-title":"Systematic review of rosacea treatments","volume":"56","author":"van Zuuren","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.optm.2010.01.015_bib50","first-page":"183","article-title":"The comparative efficacy of sodium sulfacetamide 10%\/sulfur 5% (Sulfacet-R\u00ae) lotion and metronidazole 0.75% (Metrogel\u00ae) in the treatment of rosacea","volume":"3","author":"Lebwohl","year":"1995","journal-title":"J\u00a0Geriatr Dermatol"},{"issue":"5","key":"10.1016\/j.optm.2010.01.015_bib51","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1468-3083.2009.03132.x","article-title":"Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin","volume":"23","author":"Bakar","year":"2009","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"6","key":"10.1016\/j.optm.2010.01.015_bib52","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1067\/mjd.2001.114739","article-title":"Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report","volume":"44","author":"Goldman","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.optm.2010.01.015_bib53","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0190-9622(03)02157-1","article-title":"Tacrolimus effect on rosacea","volume":"50","author":"Bamford","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.optm.2010.01.015_bib54","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1468-3083.2008.02589.x","article-title":"A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea","volume":"22","author":"Karabulut","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.optm.2010.01.015_bib55","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1365-2133.2006.07669.x","article-title":"Pimecrolimus cream 1% for papulopustular rosacea: A randomized vehicle-controlled double-blind trial","volume":"156","author":"Weissenbacher","year":"2007","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.optm.2010.01.015_bib56","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000065849","article-title":"Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea: A randomized double-blind placebo-controlled study","volume":"205","author":"Ko\u00e7ak","year":"2002","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.optm.2010.01.015_bib57","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2230.2009.03427.x","article-title":"A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea: a randomized open-label clinical trial","volume":"35","author":"Koca","year":"2010","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.optm.2010.01.015_bib58","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2133.2009.09241.x","article-title":"The metabolism and pharmacokinetics of isotretinoin in patients with acne and rosacea are not influenced by ethanol","volume":"161","author":"Gr\u00f8nh\u00f8j Larsen","year":"2009","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.optm.2010.01.015_bib59","first-page":"65","article-title":"Children and dry eye","volume":"146","author":"Pietrantonio","year":"2009","journal-title":"Rev Optom"},{"issue":"1","key":"10.1016\/j.optm.2010.01.015_bib60","first-page":"23","article-title":"Topical therapies for rosacea","volume":"5","author":"Nally","year":"2006","journal-title":"J Drugs Dermatol"},{"issue":"11","key":"10.1016\/j.optm.2010.01.015_bib61","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/archderm.143.11.1369","article-title":"Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist, oxymetazoline","volume":"143","author":"Shanler","year":"2007","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.optm.2010.01.015_bib62","first-page":"82","article-title":"Put the squeeze in meibomian gland disease","volume":"146","author":"Pitts","year":"2009","journal-title":"Rev Optom"},{"issue":"7","key":"10.1016\/j.optm.2010.01.015_bib63","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/OPX.0b013e3180dc99d5","article-title":"Warm compress induced visual degradation and Fischer-Schweitzer polygonal reflex","volume":"84","author":"Solomon","year":"2007","journal-title":"Optom Vis Sci"},{"issue":"1","key":"10.1016\/j.optm.2010.01.015_bib64","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0022-3565(24)35272-3","article-title":"Anti-inflammatory activity of macrolide antibiotics","volume":"292","author":"Ianaro","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.optm.2010.01.015_bib65","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1517\/14656566.5.10.2099","article-title":"Topical 0.05% cyclosporine in the treatment of dry eye","volume":"5","author":"Perry","year":"2004","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"10.1016\/j.optm.2010.01.015_bib66","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10792-009-9311-1","article-title":"Fungal keratitis associated with ocular rosacea","volume":"30","author":"Jain","year":"2010","journal-title":"Int Ophthalmol"},{"issue":"7","key":"10.1016\/j.optm.2010.01.015_bib67","first-page":"664","article-title":"Anti-inflammatory dose doxycycline in the treatment of rosacea","volume":"8","author":"Del Rosso","year":"2009","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.optm.2010.01.015_bib68","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1517\/14740338.7.5.571","article-title":"The use and safety of doxycycline hyclate and other second-generation tetracyclines","volume":"7","author":"Sloan","year":"2008","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"10.1016\/j.optm.2010.01.015_bib69","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3341\/kjo.2005.19.4.258","article-title":"The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction","volume":"19","author":"Yoo","year":"2005","journal-title":"Korean J Ophthalmol"},{"issue":"6","key":"10.1016\/j.optm.2010.01.015_bib70","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.mehy.2009.02.049","article-title":"Intestinal alkaline phosphatase: The molecular link between rosacea and gastrointestinal disease?","volume":"73","author":"Whitehead","year":"2009","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.optm.2010.01.015_bib71","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0039-6257(86)90034-2","article-title":"Ocular rosacea","volume":"31","author":"Browning","year":"1986","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"10.1016\/j.optm.2010.01.015_bib72","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0181-5512(06)70106-1","article-title":"Improvement of dry eye symptoms with polyunsaturated fatty acids","volume":"29","author":"Creuzot","year":"2006","journal-title":"J Fr Ophthalmol"},{"issue":"2","key":"10.1016\/j.optm.2010.01.015_bib73","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archophthalmol.2007.61","article-title":"Topical omega-3 and omega-6 fatty\u00a0acids for treatment of dry eye","volume":"126","author":"Rashid","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.optm.2010.01.015_bib74","first-page":"62","article-title":"The essentials of essential fatty acids","volume":"146","author":"Alexander","year":"2009","journal-title":"Rev Optom"},{"issue":"64","key":"10.1016\/j.optm.2010.01.015_bib75","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2146\/ajhp060164","article-title":"Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia","volume":"15","author":"McKenny","year":"2007","journal-title":"Am J Health-Syst Pharm"},{"issue":"2","key":"10.1016\/j.optm.2010.01.015_bib76","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/09546630802314662","article-title":"The cost-effectiveness of\u00a0rosacea treatments","volume":"20","author":"Thomas","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.optm.2010.01.015_bib77","first-page":"135","article-title":"Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea","volume":"76","author":"Draelos","year":"2005","journal-title":"Cutis"},{"issue":"2","key":"10.1016\/j.optm.2010.01.015_bib78","first-page":"72","article-title":"The use of moisturizers as an integral component of topical therapy for rosacea: clinical results based on the Assessment of Skin Characteristics Study","volume":"84","author":"Del Rosso","year":"2009","journal-title":"Cutis"},{"issue":"5","key":"10.1016\/j.optm.2010.01.015_bib79","first-page":"459","article-title":"Topical PRK 124 (0.125%) lotion for improving the signs and symptoms of rosacea","volume":"8","author":"Ortiz","year":"2009","journal-title":"J Drugs Dermatol"}],"container-title":["Optometry - Journal of the American Optometric Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152918391000655X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152918391000655X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T04:58:10Z","timestamp":1740891490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152918391000655X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S152918391000655X"],"URL":"https:\/\/doi.org\/10.1016\/j.optm.2010.01.015","relation":{},"ISSN":["1529-1839"],"issn-type":[{"value":"1529-1839","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}